DelveInsight Blogs Sitemap

All Posts in this category
S.No. Product Name Actions
1 AstraZeneca's Ultomiris; HebaBiz's Siroquine; Pfizer's XELJANZ; Bristol Myers Squibb's Opdivo; and Masimo's PVi Visit Post
2 Fight Against the Antibiotic Resistance in the Uncomplicated Urinary Tract Infections Market Visit Post
3 BlueRock secures FDA fast track; Omniscient rakes in $29M; Neuspera’s nerve implant gets a $65M boost Rivus’ therapy nabs $35M Visit Post
4 Bayer's CKD Drug; Enochian’s RNA Hijack for HBV; Novo Nordisk's to get Prothena's ATTR Amyloidosis Business; J&J’s COVID-19 Vaccine Struggle Visit Post
5 Horizon/ Arrowhead Deal; Dr Reddy's Lab’s Drug US Launch; Targovax’s ONCOS-102; RedHill's Oral Opaganib in COVID-19 Visit Post
6 Renal Tubular Acidosis Therapy Market and Sub-Optimally Effective Standard of Care Visit Post
7 Market Heats Up as Managing Benign Prostatic Hyperplasia Through Devices Gains Traction Visit Post
8 Merck, Eisai in renal cancer market; G1 Therapeutics on Cosela’s approval; Takeda's Maribavir; Astellas/Seagen Padcev Visit Post
9 A Globally Rising Burden of Sexually Transmitted Diseases (STDs) Visit Post
10 Nestle to acquire Aimmune Therapeutics; Vir Bio & GSK's COVID-19 monoclonal antibody therapy; AstraZeneca's Farxiga scores goal in Phase III CDK trial Visit Post
11 Interstitial Cystitis: A big opportunities for emerging drugs Visit Post
12 Watch Out for the Most Promising Therapies in the Pipeline in Acute Kidney Injury Market Visit Post
13 Emerging Therapies that can significantly impact the Acute Kidney Injury Market Visit Post
14 Novome raises USD 33M, Buyout of Bioniz, Adagene raises USD 69M Visit Post
15 Autologous cell therapy market: A new paradigm for kidney diseases Visit Post
16 GHO to advance healthcare in Europe; Truvian nets USD 27.1 Mn; Lilly plans its diabetes portfolio expansion Visit Post
17 World Kidney Day Visit Post
18 WORLD AIDS DAY - 2018 Visit Post
19 Calciphylaxis: Rare Yet Potentially Fatal Visit Post
20 Notizia Visit Post
21 Notizia Visit Post
22 Hyperuricemia – Uric acid disorder, a gateway to other diseases Visit Post
23 The Business Cocktail : Latest Pharma deals Visit Post
24 Teva sells generics; Valeant trades; Roche's Genentech; J&J's next potential frontier Visit Post
25 Interstitial Cystitis : Promising Scope for Research Visit Post
26 Urinary Tract Infections (UTIs)– How is it affecting the Globe? Visit Post
27 Invokana matches; Xultophy beats; Lilly and BI follow; Tresiba matches Visit Post
28 Insight on Interstitial Cystitis- The Bladder Pain Syndrome Visit Post
29 Urinary Incontinence: Epidemiology Insight on Leaking Bladder Visit Post
30 The Current Scenario for Interstitial Cystitis(IC) Visit Post
31 USFDA warns; Vit B3 prevents glaucoma; Zydus Cadila receives nod; U.S. experts soften on DNA editing Visit Post
32 Chronic Kidney Disease: Complex Debilitating Condition Visit Post
33 mTOR Inhibitors-Emerging therapy in various therapeutic areas Visit Post
34 Bayer AG & Evotec AG’s deal; Plasticell and CellSpring AG’s deal; Allergan Acquires Akarna; Cambrex Acquires Pharmacore Visit Post
35 DelveInsight’s Genitourinary Sex hormones based Gene Therapy Reports Visit Post
36 Metastatic Prostate Cancer-Pipeline Insights, 2014 Visit Post